Compare ITT & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ITT | HOLX |
|---|---|---|
| Founded | 1920 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Fluid Controls | Medical Electronics |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.0B | 16.9B |
| IPO Year | 1994 | 1995 |
| Metric | ITT | HOLX |
|---|---|---|
| Price | $196.06 | $76.02 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 13 |
| Target Price | ★ $216.45 | $77.89 |
| AVG Volume (30 Days) | 885.2K | ★ 6.4M |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | ★ 0.80% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 6.11 | 0.79 |
| Revenue | $3,938,500,000.00 | ★ $4,100,500,000.00 |
| Revenue This Year | $35.36 | $4.74 |
| Revenue Next Year | $11.20 | $5.03 |
| P/E Ratio | ★ $31.75 | $96.23 |
| Revenue Growth | ★ 8.48 | 1.74 |
| 52 Week Low | $111.02 | $51.90 |
| 52 Week High | $209.70 | $76.07 |
| Indicator | ITT | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 55.95 | 69.09 |
| Support Level | $179.08 | $75.10 |
| Resistance Level | $196.82 | N/A |
| Average True Range (ATR) | 5.72 | 0.19 |
| MACD | 1.07 | 0.03 |
| Stochastic Oscillator | 95.81 | 95.19 |
ITT began its journey as International Telephone & Telegraph in 1920. Through decades of acquisitions in the mid-1900s, ITT went from manufacturing telephone switching equipment to operating hotels, car rentals, insurance agencies, and bread bakeries. In 1995, the firm split into three separate entities, one of which is the ITT in current operation. After a few more spinoffs in 2011, today ITT Inc. sells automotive, industrial, and aerospace products such as brake pads, seals, pumps, valves, connectors, and regulators. It has operations around the globe with notable exposures to North America, Europe, and Asia.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.